Quercetin and allopurinol reduce liver thioredoxin‐interacting protein to alleviate inflammation and lipid accumulation in diabetic rats
British Journal of Pharmacology2013Vol. 169(6), pp. 1352–1371
Citations Over TimeTop 10% of 2013 papers
Wei Wang, Chuang Wang, Xiaoqin Ding, Ying Pan, Tingting Gu, Mingxing Wang, Yang‐Liu Liu, Fu‐Meng Wang, Shui‐Juan Wang, Ling‐Dong Kong
Abstract
Inhibition of hepatic TXNIP by quercetin and allopurinol contributes to the reduction in liver inflammation and lipid accumulation under hyperglycaemic conditions. The targeting of hepatic TXNIP by quercetin and allopurinol may have therapeutic implications for prevention of type 1 diabetes-associated NAFLD.
Related Papers
- → The structural basis for the negative regulation of thioredoxin by thioredoxin-interacting protein(2014)187 cited
- → Up-regulation of thioredoxin interacting protein (Txnip) by p38 MAPK and FOXO1 contributes to the impaired thioredoxin activity and increased ROS in glucose-treated endothelial cells(2009)130 cited
- → Thioredoxin-Interacting Protein Stimulates Its Own Expression via a Positive Feedback Loop(2014)37 cited
- → Hyperglycemia Regulates TXNIP/TRX/ROS Axis via p38 MAPK and ERK Pathways in Pancreatic Cancer(2014)30 cited
- → The role of serum levels of thioredoxin and thioredoxin-interacting protein in stroke(2018)2 cited